OrbitonOpen research workspace →
Novo Nordisk A/S logo

Novo Nordisk A/S

TSX:NOVOLive AI agent

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark.

Investor website: https://novonordisk.com/

About

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. The company focuses on pioneering scientific breakthroughs, expanding access to medicines, and forming strategic partnerships to create meaningful change for millions living with chronic diseases. Their innovative treatments and support aim to help people achieve lasting health.

Verified company data

Shares outstanding
4453.9
Fully diluted shares
4463.0
Projects
["Liver Health in Focus is a series of episodes sponsored by Novo Nordisk featuring expert discussions on current topics related to the diagnosis and treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) or metabolic dysfunction-associated steatohepatitis (MASH)."]
Leadership
Lars Fruergaard Jørgensen (President and Chief Executive Officer (CEO), President of the European Federation of Pharmaceutical Industries and Associations. Member of the board of directors at Danmarks Nationalbank.), Maziar Mike Doustdar (Executive Vice President, International Operations), Ludovic Helfgott (Executive Vice President, Rare Disease, President of the Novo Nordisk Haemophilia Foundation Council.), Karsten Munk Knudsen (Executive Vice President, Chief Financial Officer (CFO), Member of the board of directors and chair of the audit committee of Hempel A/S.), Martin Holst Lange (Executive Vice President, Development, Member of the board of directors of Pharmacosmos A/S.), David Moore (Executive Vice President, US Operations & Business Development, Member of the board of directors of Novasenta Inc.), Tania Sabroe (Executive Vice President, Global People & Organisation), Marcus Schindler (Executive Vice President, Research & Early Development and Chief Scientific Officer (CSO), Adjunct Professor of Pharmacology at the University of Gothenburg.), Camilla Sylvest (Executive Vice President, Commercial Strategy & Corporate Affairs, Member of the board of directors of Danish Crown A/S and Argenx SE.), Henrik Wulff (Executive Vice President, Product Supply, Quality & IT, Member of the board of directors of Grundfos Holding A/S.)

Verified data last updated:

Recent filings